AstraZeneca Farmaceutica Spain, S.A. secures contract for Influenza vaccines - Provision of attenuated intranasal influenza vaccine for administration to children from 2 years of age for the vaccination program according to the Schedule of systematic vaccinations and immunizations throughout the life of the person

Spain, Oct. 1 -- Spain based AstraZeneca Farmaceutica Spain, S.A. has secured contract from Consejeria de Sanidad y Bienestar Social de la Junta de Castilla y Leon for Influenza vaccines - Provision of attenuated intranasal influenza vaccine for administration to children from 2 years of age for the vaccination program according to the Schedule of systematic vaccinations and immunizations throughout the life of the person . The value of the contract is not disclosed .

Published by HT Digital Content Services with permission from Pivotal Sources....